GeneDx Holdings (WGS) EBIT Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 13.79% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | 48.29% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 14.08% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 33.00% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | 0.00% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | -18.11% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | 14.49% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | 17.41% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | 4.79% |
| 10 | GeneDx Holdings | 2.03 Bn | 1.90 Bn | 78.24 Mn | -294.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -294.81% |
| Mar 31, 2026 | -1,162.82% |
| Dec 31, 2025 | -261.65% |
| Sep 30, 2025 | 58.21% |
| Jun 30, 2025 | 184.70% |
| Mar 31, 2025 | 66.68% |
| Dec 31, 2024 | 134.34% |
| Sep 30, 2024 | 81.89% |
| Jun 30, 2024 | 79.51% |
| Mar 31, 2024 | 77.37% |
| Dec 31, 2023 | 92.11% |
| Sep 30, 2023 | 52.69% |
| Jun 30, 2023 | 68.26% |
| Mar 31, 2023 | 32.41% |
| Dec 31, 2022 | -180.60% |
| Sep 30, 2022 | -2.89% |
| Jun 30, 2022 | -257.88% |
| Mar 31, 2022 | 54.59% |
| Dec 31, 2021 | 7.41% |
| Sep 30, 2021 | -57.57% |